It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing
Lowers risk of heart disease Common Side Effects Nausea Diarrhea Vomiting Constipation Stomach (abdomen) pain Headache Fatigue Upset stomach Dizziness Feeling Bloated Belching Gas Stomach Flu Heartburn More serious side affects can include gall stones, hypoglycemia, possible thyroid tumors, kidney problems or serious allergic reactions
Latif W, Lambrinos KJ, Rodriguez R
We assess dosing, protein and fiber intake, hydration, activity, and step goals